인쇄하기
취소

SK Chemicals’ joint sales and marketing agreement of SKY Zoster with Daewoong

Published: 2018-05-14 17:28:48
Updated: 2018-05-14 17:28:48

‘SKY Zoster,’ the first shingles vaccine developed by an Korean pharmaceutical company and become a blockbuster medicinal drug with collective sales of KRW 10 billion this year, will have more active marketing activities in the market.

SK Chemicals(CEO Man-Hoon Park) announced conclusion of a joint marketing and sales agreement of the shingles vaccine ‘SKY Zoster’ with Daewoong Pharmaceutical ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.